[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Bone Metastasis Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4              By Type Overview

4.1          Introduction

4.1.1      Market Size & Forecast (Value)

4.2          Osteolytic Bone Metastasis

4.3          Osteoblastic Bone Metastasis

4.4          Mixed Bone Metastasis

4.5          Others

5              By Diagnosis

5.1          Introduction

5.1.1      Market Size & Forecast (Value)

5.2       Biopsy

5.3       Blood Test

5.4     Imaging

5.5          X-ray

5.6          Bone Scintigraphy

5.7          Computerized Tomography

5.8          Magnetic Resonance Imaging

5.9          Positron Emission Tomography

5.10        Others

6              By Treatment Overview

6.1          Introduction

6.1.1      Market Size & Forecast (Value)

6.2          Medical Therapies

6.2.1      Chemotherapy

6.2.2      Targeted Therapy

6.2.3      Hormone Therapy

6.2.4      Ablation Therapy

6.2.5      Others

6.3          Surgery

6.3.1      Vertebroplasty

6.3.2      Kyphoplasty

6.3.3      Others

6.4          Medication

6.4.1      Medications

6.4.2      Bone Building Medications

6.4.3      Others

7.            By End-User Overview

7.1          Introduction

7.1.1      Market Size & Forecast (Value)

7.2          Hospitals & Clinics

7.3          Diagnostic Centers

7.4          Pharmacies

7.5          Ambulatory Surgical Centers

8              Regional Overview

8.1          Introduction

8.1.1      Market Size & Forecast (Value)

8.2          America

8.2.1      North America

8.2.1.1   U.S.

8.2.1.1.1               By Type

8.2.1.1.2               By Diagnosis

8.2.2      Canada

8.2.2.1   By Type

8.2.2.2   By Diagnosis

8.2.3      Mexico

8.2.3.1   By Type

8.2.3.2   By Diagnosis

8.2.4      Latin America

8.2.4.1   By Type

8.2.4.2   By Diagnosis

8.3          Europe

8.3.1      Market Size & Forecast (Value)

8.3.2      Germany

8.3.2.1   By Type

8.3.2.2   By Diagnosis

8.3.3      France

8.3.3.1   By Type

8.3.3.2   By Diagnosis

8.3.4      U.K.

8.3.4.1   By Type

8.3.4.2   By Diagnosis

8.3.5      Italy

8.3.5.1   By Type

8.3.5.2   By Diagnosis

8.3.6      Spain

8.3.6.1   By Type

8.3.6.2   By Diagnosis

8.3.7      Rest of Europe

8.3.7.1   By Type

8.3.7.2   By Diagnosis

8.4          Asia Pacific

8.4.1      Market Size & Forecast (Value)

8.4.2      Japan

8.4.2.1   By Type

8.4.2.2   By Diagnosis

8.4.3      China

8.4.3.1   By Type

8.4.3.2   By Diagnosis

8.4.4      Australia

8.4.4.1   By Type

8.4.4.2   By Diagnosis

8.4.5      India

8.4.5.1   By Type

8.4.5.2   By Diagnosis

8.4.6      South Korea

8.4.6.1   By Type

8.4.6.2   By Diagnosis

8.4.7      Rest of Asia-Pacific

8.4.7.1   By Type

8.4.7.2   By Diagnosis

8.5          Middle East & Africa

8.5.1      Market Size & Forecast (Value)

8.5.2      Saudi Arabia

8.5.2.1   By Type

8.5.2.2   By Diagnosis

8.5.3      South Africa

8.5.3.1   By Type

8.5.3.2   By Diagnosis

8.5.4      Kuwait

8.5.4.1   By Type

8.5.4.2   By Diagnosis

8.5.5      Rest of Middle East & Africa

8.5.5.1   By type

8.5.5.2   By Diagnosis

9.    Company Profile    

9.1          Bayer AG, Merck & Co.

9.1.1      Company Overview

9.1.2      Financial Performance

9.1.3      Recent Developments

9.1.4      Product Portfolio

9.2          Pfizer Inc.

9.2.1      Company Overview

9.2.2      Financial Performance

9.2.3      Recent Developments

9.2.4      Product Portfolio

9.3          Siemens AG

9.3.1      Company Overview

9.3.2      Financial Performance

9.3.3      Recent Developments

9.3.4      Product Portfolio

9.4          Koninklijke Philips N.V.

9.4.1      Company Overview

9.4.2      Financial Performance

9.4.3      Recent Developments

9.4.4      Product Portfolio

9.5          TOSHIBA CORPORATION

9.5.1      Company Overview

9.5.2      Financial Performance

9.5.3      Recent Developments

9.5.4      Product Portfolio

9.6          GENERAL ELECTRIC

9.6.1      Company Overview

9.6.2      Financial Performance

9.6.3      Recent Developments

9.6.4      Product Portfolio

9.7          Siemens AG

9.7.1      Company Overview

9.7.2      Financial Performance

9.7.3      Recent Developments

9.7.4      Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports